Zeltiq Aesthetics Inc (ZLTQ) : 12 West Capital Management Lp scooped up 209,439 additional shares in Zeltiq Aesthetics Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 800,229 shares of Zeltiq Aesthetics Inc which is valued at $31,713,075.Zeltiq Aesthetics Inc makes up approximately 4.92% of 12 West Capital Management Lp’s portfolio.
Other Hedge Funds, Including , Williams Jones Associates sold out all of its stake in ZLTQ during the most recent quarter. The investment firm sold 10,000 shares of ZLTQ which is valued $396,300. Checchi Capital Advisers sold out all of its stake in ZLTQ during the most recent quarter. The investment firm sold 12 shares of ZLTQ which is valued $475. Zevenbergen Capital Investments added ZLTQ to its portfolio by purchasing 283,860 company shares during the most recent quarter which is valued at $11,235,179. Zeltiq Aesthetics Inc makes up approx 0.47% of Zevenbergen Capital Investments’s portfolio.California State Teachers Retirement System boosted its stake in ZLTQ in the latest quarter, The investment management firm added 700 additional shares and now holds a total of 75,051 shares of Zeltiq Aesthetics Inc which is valued at $2,572,748. Zeltiq Aesthetics Inc makes up approx 0.01% of California State Teachers Retirement System’s portfolio.Provident Investment Management reduced its stake in ZLTQ by selling 3,252 shares or 0.77% in the most recent quarter. The Hedge Fund company now holds 416,794 shares of ZLTQ which is valued at $15,062,935. Zeltiq Aesthetics Inc makes up approx 3.16% of Provident Investment Management’s portfolio.
Zeltiq Aesthetics Inc closed down -0.25 points or -0.58% at $42.52 with 4,95,175 shares getting traded on Monday. Post opening the session at $42.45, the shares hit an intraday low of $42.18 and an intraday high of $42.8889 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Zeltiq Aesthetics Inc reported $0.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Nov 9, 2016. Analyst had a consensus of $0.08. The company had revenue of $95.20 million for the quarter, compared to analysts expectations of $90.95 million. The company’s revenue was up 55.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.05 EPS.
Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Company shares were Reiterated by Canaccord Genuity on Nov 10, 2016 to “Buy”, Firm has raised the Price Target to $ 45 from a previous price target of $41 .Company shares were Reiterated by Stifel on Sep 21, 2016 to “Buy”, Firm has raised the Price Target to $ 52 from a previous price target of $38 .
ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.